<IPO>MEDTIDE (03880.HK) Begins IPO Tdy w/ Entry Fee $3,091, Introduces CSPC PHARMA as Cornerstone Investor
CRDMO MEDTIDE (03880.HK) announced details of its Hong Kong IPO, planning to globally offer 16.8...
CRDMO MEDTIDE (03880.HK) announced details of its Hong Kong IPO, planning to globally offer 16.8 million H shares, with 10% (approx. 1.68 million shares) for Hong Kong public offering and 90% (15.12 million shares) for international placement.
The offer price ranges from $28.4 to $30.6 per share, aiming to raise a maximum amount of approx. $514 million. The entry fee for a board lot of 100 shares is around $3,090.85.
The offering period starts today (20th), and will end next Wednesday (25th), with listing expected on 30 June. Morgan Stanley and CITIC Securities are its joint sponsors.
In this IPO, MEDTIDE introduced CSPC PHARMA (01093.HK) and Welight Capital, founded by former TENCENT (00700.HK) executive Wu Xiaoguang, as cornerstone investors, subscribing shares equivalent to US$5 million each.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-19 16:25.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
